Autologous MSC from adipose (University Hospital, Toulouse)

自体脂肪源间充质干细胞（(University Hospital, Toulouse）

Report date: 2023/11/14 20:00:32

Base Information

Drug NameAutologous MSC from adipose (University Hospital, Toulouse)

Drug Alias NameAdipose-derived Stem/Stroma CellAutologous ASC

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsScleroderma, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesToulouse University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesToulouse University Hospital

Inactive CompaniesN/A

Active IndicationsScleroderma, Systemic

Inactive IndicationsN/A

Other Information

ATC CodeN/A